Workflow
康弘药业股价跌6.29%,工银瑞信基金旗下1只基金重仓,持有17.28万股浮亏损失42.34万元

Group 1 - The core viewpoint of the news is that Kanghong Pharmaceutical experienced a significant stock decline of 6.29%, with its share price at 36.51 yuan and a total market capitalization of 33.637 billion yuan as of the report date [1] - Kanghong Pharmaceutical, established on October 3, 1996, and listed on June 26, 2015, is primarily engaged in the research, production, and sales of chemical drugs, traditional Chinese medicine, and biological products [1] - The revenue composition of Kanghong Pharmaceutical is as follows: biological drugs account for 54.83%, traditional Chinese medicine 32.49%, chemical drugs 12.50%, and other categories 0.15% [1] Group 2 - From the perspective of fund holdings, one fund under Industrial Bank of China Asset Management has a significant position in Kanghong Pharmaceutical, with 172,800 shares held, representing 1.29% of the fund's net value [2] - The fund, named Industrial Flexible Allocation Mixed A (487016), has a total scale of 389 million yuan and has achieved a year-to-date return of 14.49% [2] - The fund manager, Li Yu, has been in position for 7 years and 234 days, with the best return during his tenure being 153.76% [2]